Quantcast

Latest Hodgkin's lymphoma Stories

2014-06-02 23:05:52

Transparency Market Research added a new report "Global Natural Killer Cell Lymphomas Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/natural-killer-cell-lymphomas.html. Albany, New York (PRWEB) June 02, 2014 Lymphoma is a common blood cancer type which develops when lymphocytes multiply in an uncontrolled manner. There are two types of lymphomas- Hodgkin’s and...

2014-05-31 08:21:05

- Data include results from two Phase I studies of ABT-199/GDC-0199 in relapsed/refractory chronic lymphocytic leukemia (CLL) and various subtypes of non-Hodgkin's lymphoma (NHL) NORTH CHICAGO, Ill., May 31, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) released interim results from a Phase Ib clinical trial of ABT-199/GDC-0199, an investigational B-cell lymphoma 2 (BCL-2) selective inhibitor, in combination with rituximab (Abstract 7013). Results showed an overall response rate (ORR) of...

2014-05-19 08:29:00

WHITE PLAINS, N.Y., May 19, 2014 /PRNewswire-USNewswire/ -- Foundation Beyond Belief (FBB), a team of atheists, humanists and religious allies, just completed their second year with The Leukemia & Lymphoma Society's (LLS) Light The Night® fundraising campaign. FBB is a national partner in support of LLS's mission to find cures and ensure access to treatments for patients with blood cancers. As a Special Friend of Light The Night, FBB has raised $930,000 to date. In their first...

2014-05-15 12:28:11

Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., May 15, 2014 /PRNewswire-iReach/ -- In his new book, God's Cure For Cancer: No chemotherapy, No radiation, No surgery ($14.99, paperback, 9781629522029; $6.99, e-book, 9781629522036) Weston L. Blair, Ph.D. tells the remarkable story of how God healed him from Stage 4 Non-Hodgkin's Lymphoma. The author's full recovery was made possible only through the Word of God. Furthermore, he was...

2014-04-29 16:25:50

Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., April 29, 2014 /PRNewswire-iReach/ -- In his new book, God's Cure For Cancer: No chemotherapy, No radiation, No surgery ($12.99, paperback, 9781629522029; $6.99, e-book, 9781629522036) Weston L. Blair, Ph.D. tells the remarkable story of how God healed him from Stage 4 Non-Hodgkin's Lymphoma. The author's full recovery was made possible only through the Word of God. Furthermore, he was...

2014-04-29 04:21:45

- First and Only Approved Monotherapy in the EU for this Patient Population - BIRMINGHAM, England, April 29, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the launch of PIXUVRI® (pixantrone), the first new treatment for adult patients in the United Kingdom (UK) with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (aggressive B-cell NHL), at the 54(th) annual scientific meeting of the British Society for Haematology. PIXUVRI...

2014-04-24 08:33:54

Patent covers methods of use for small molecule inhibitors in the treatment of NHL, including follicular and diffuse large B-cell lymphomas CAMBRIDGE, Mass., April 24, 2014 /PRNewswire-USNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the U.S. Patent and Trademark Office has granted a notice of allowance for U.S. Patent Application...

2014-04-08 12:31:36

Community Leaders throughout the North Bay Area Assemble to Join LLS in the Fight against Blood Cancers SANTA ROSA, Calif., April 8, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter is launching its 2014 North Bay Man & Woman of the Year (MWOY) fundraising campaign, enlisting influential and compassionate community leaders as candidates competing to raise funds for blood cancer research and cures. In its second year, the North...

2014-04-08 08:30:17

Patent provides protection until 2033 and complements Epizyme's issued composition of matter claims for EZH2 inhibitors CAMBRIDGE, Mass., April 8, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,691,507 with claims that cover the identification of patients...

2014-04-02 12:31:39

New Program Brings Busy Moms Together to Get In Shape, Meet Other Moms and Raise Funds to Help Fight Cancer SAN FRANCISCO, April 2, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter has launched Moms In Training, a brand new nine-week workout program geared towards helping busy moms prepare for a 5K race, while meeting other moms in their community and raising funds for LLS's mission to fight blood cancer. Moms In Training is based...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related